Detalhe da pesquisa
1.
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A.
Blood
; 128(5): 630-7, 2016 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27330001
2.
Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study.
Am J Hematol
; 98(9): E233-E236, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37354069
3.
Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS-1211, a tissue-nonspecific alkaline phosphatase inhibitor.
Clin Transl Sci
; 15(4): 967-980, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35021269
4.
Safety and Pharmacokinetics of DS-1040 Drug-Drug Interactions With Aspirin, Clopidogrel, and Enoxaparin.
J Clin Pharmacol
; 60(6): 691-701, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106339
5.
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS-1040, an Inhibitor of the Activated Form of Thrombin-Activatable Fibrinolysis Inhibitor, in Healthy Subjects.
J Clin Pharmacol
; 59(12): 1669-1677, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243790
6.
Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.
J Med Chem
; 46(10): 1989-96, 2003 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-12723961